Finance

Lists
038070:KOSDAQ
Seoulin Bioscience Co Ltd
â‚©3,990.00
-1.85%
(-75.00) 1D
Sep 21, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 038070...
Open
â‚©4,195
High
â‚©4,195
Low
â‚©3,805
Mkt. cap
37.11B
Avg. vol.
26.78K
Volume
44.14K
Dividend
2.45%
Quarterly dividend
â‚©24
Ex-dividend date
Dec 29, 2021
P/E ratio
39.96
52-wk high
â‚©7,760
52-wk low
â‚©3,600
EPS
â‚©100
Shares outstanding
9.30M
No. of employees
104
Open
â‚©4,195
High
â‚©4,195
Low
â‚©3,805
Mkt. cap
37.11B
Avg. vol.
26.78K
Volume
44.14K
Dividend
2.45%
Quarterly dividend
â‚©24
Ex-dividend date
Dec 29, 2021
P/E ratio
39.96
52-wk high
â‚©7,760
52-wk low
â‚©3,600
EPS
â‚©100
Shares outstanding
9.30M
No. of employees
104
About Seoulin Bioscience Co Ltd
CEO-
Employees104
Founded1984
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
22.87B
19.96B
19.53B
20.80B
Cost of goods sold
17.75B
15.42B
15.08B
17.17B
Cost of revenue
17.75B
15.42B
15.08B
17.17B
Research and development expenses
238.24M
151.88M
212.16M
256.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.46B
4.04B
3.58B
3.43B
Operating expense
4.34B
4.40B
4.28B
4.23B
Total operating expenses
22.09B
19.82B
19.35B
21.40B
Operating income
784.70M
142.28M
174.55M
-597.45M
Other non operating income
15.28M
533.61M
43.66M
1.52B
EBT including unusual items
776.92M
-391.36M
154.36M
452.87M
EBT excluding unusual items
753.24M
490.88M
147.40M
895.85M
Income tax expense
21.67M
12.84M
2.95M
110.66M
Effective tax rate
2.79%
-3.28%
1.91%
24.43%
Other operating expenses
145.64M
86.57M
143.51M
130.62M
Net income
766.94M
-355.69M
163.16M
342.21M
Net profit margin
3.35%
-1.78%
0.84%
1.65%
Earnings per share
-
-
-
-
Interest and investment income
220.26M
236.78M
229.38M
228.24M
Interest expense
-280.56M
-295.65M
-340.19M
-364.11M
Net interest expenses
-60.30M
-58.87M
-110.81M
-135.86M
Depreciation and amortization charges
242.48M
247.26M
264.16M
290.14M
EBITDA
1.06B
426.51M
474.74M
-272.42M
Gain or loss from assets sale
-
-
-
3.00K
AI content may include mistakes. Learn more
Google apps